Reprint of Editiorial Commentary: Genomics and drug discovery: The next frontier in precision medicine

Precision medicine has come to mean many things to many people —a perfectly precise diagnosis and treatment, incorporation of electronic health records (EHRs), and genomic information into routine clinical care, or expanded consideration of sociocultural factors in decision-making [1]. In this issue of Trends in Cardiovascular Medicine, Stitziel and Kathiresa n [2] outline an emerging frontier in this area, the use of human genetics to identify and validate new targets for drug development. This may turn out to be an especially interesting area since new drug development is extraordinarily expensive and the number of compounds failing in late development extracts a big toll not only on the availability of new therapies but also on their costs, which have to absorb the costs of failed drug candidates [3].
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Source Type: research